1. The Development of Pharmacophore Models for the Search of New Natural Inhibitors of SARS-CoV-2 Spike RBD–ACE2 Binding Interface
    Valentin A. Semenov et al, 2022, Molecules CrossRef
  2. Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review)
    Periklis Katopodis et al, 2021, International Journal of Molecular Medicine CrossRef
  3. The Role of Alveolar Edema in COVID-19
    Shu Yuan et al, 2021, Cells CrossRef
  4. Molecular Modeling of Viral Type I Fusion Proteins: Inhibitors of Influenza Virus Hemagglutinin and the Spike Protein of Coronavirus
    Sophia S. Borisevich et al, 2023, Viruses CrossRef
  5. CAN BAICALEIN BECOME A NEW DRUG FOR COVID-19?
    Jiří Patočka et al, 2021, Military Medical Science Letters CrossRef
  6. The Crosstalk between SARS-CoV-2 Infection and the RAA System in Essential Hypertension—Analyses Using Systems Approach
    Dorota Formanowicz et al, 2021, International Journal of Molecular Sciences CrossRef
  7. Borneol Ester Derivatives as Entry Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses
    Olga I. Yarovaya et al, 2022, Viruses CrossRef
  8. Simulation of Molecular Dynamics of SARS-CoV-2 S-Protein in the Presence of Multiple Arbidol Molecules: Interactions and Binding Mode Insights
    Sophia S. Borisevich et al, 2022, Viruses CrossRef